|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
|
EP0560410B1
(en)
|
1987-04-27 |
2002-10-02 |
Inverness Medical Switzerland GmbH |
A test device for performing specific binding assays
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
|
PT582368E
(pt)
|
1992-05-29 |
2001-05-31 |
Lilly Co Eli |
Derivados de tienobenzodiazepina para o tratamento de doencas de cns
|
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
|
EP0804580B1
(en)
|
1994-06-10 |
2008-10-08 |
Oklahoma Medical Research Foundation |
Calcium binding recombinant antibody against protein c
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
|
WO1998059233A1
(en)
|
1997-06-23 |
1998-12-30 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US20030143233A1
(en)
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
|
KR20040094705A
(ko)
|
2002-02-21 |
2004-11-10 |
듀크 유니버시티 |
자가면역질환에 대한 시약 및 치료 방법
|
|
JP4625637B2
(ja)
|
2002-02-22 |
2011-02-02 |
シャイア エルエルシー |
活性物質送達系及び活性物質を保護し投与する方法
|
|
EP1492794B1
(en)
|
2002-03-28 |
2007-12-12 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
|
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
|
JP2005538108A
(ja)
|
2002-07-29 |
2005-12-15 |
ポトマック， ファーマ， エルエルシー |
α−２アドレナリン作動性レセプターアンタゴニストと非定型抗精神病薬精神安定薬との抗精神病薬組み合わせ治療および組成物
|
|
US7384934B2
(en)
|
2002-08-05 |
2008-06-10 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines
|
|
EP2960251A1
(en)
|
2003-05-09 |
2015-12-30 |
Duke University |
CD20-specific antibodies and methods of employing same
|
|
BRPI0413595B8
(pt)
|
2003-08-18 |
2021-05-25 |
H Lundbeck As |
sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto
|
|
WO2005028458A1
(en)
|
2003-09-23 |
2005-03-31 |
Fermion Oy |
Preparation of quetiapine
|
|
KR20140015122A
(ko)
|
2003-10-01 |
2014-02-06 |
아돌로 코포레이션 |
스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
|
|
MXPA06004489A
(es)
|
2003-10-23 |
2006-06-20 |
Otsuka Pharma Co Ltd |
Formulacion y metodo de aripiprazol inyectable esteril de liberacion controlada.
|
|
WO2005059547A2
(en)
|
2003-12-12 |
2005-06-30 |
Inverness Medical Switzerland Gmbh |
Assay
|
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
|
JP4943144B2
(ja)
|
2004-04-26 |
2012-05-30 |
松山 隆美 |
葉酸リセプターベータ（ＦＲ−β）に対する単クローン抗体を含有する治療薬
|
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
FR2878850B1
(fr)
|
2004-12-02 |
2008-10-31 |
Cis Bio Internat Sa |
Derives de l'inositol-1-phosphate
|
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
JP2010507648A
(ja)
|
2006-10-25 |
2010-03-11 |
ラモット アット テル−アビブ ユニバーシティー リミテッド |
グルタミン酸ｎｍｄａ活性を有する新規向精神薬
|
|
US20080138842A1
(en)
|
2006-12-11 |
2008-06-12 |
Hans Boehringer |
Indirect lateral flow sandwich assay
|
|
CA2672972C
(en)
|
2006-12-29 |
2015-06-23 |
Abbott Laboratories |
Diagnostic test for the detection of a molecule or drug in whole blood
|
|
CN101091700B
(zh)
|
2007-07-03 |
2011-06-08 |
上海现代药物制剂工程研究中心有限公司 |
富马酸喹硫平缓控释制剂组合物及其制备用途
|
|
EP2198309A1
(en)
|
2007-09-27 |
2010-06-23 |
Novartis Ag |
Drug monitoring assay
|
|
EP3338796A1
(en)
|
2008-07-21 |
2018-06-27 |
Probiodrug AG |
Diagnostic antibody assay
|
|
AU2009279372A1
(en)
|
2008-08-06 |
2010-02-11 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating psychiatric disorders
|
|
WO2010033270A1
(en)
|
2008-09-17 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
|
BRPI0920180B1
(pt)
|
2008-10-14 |
2021-10-26 |
Entasis Therapeutics Limited |
Compostos herecíclicos substituídos, uso dos mesmos e composiçâo farmacêutica compreendendo os ditos compostos
|
|
CA2742074A1
(en)
|
2008-10-29 |
2010-08-26 |
Janssen Pharmaceutica Nv |
Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
EP2700400A1
(en)
|
2009-01-26 |
2014-02-26 |
Egalet Ltd. |
Controlled release formulation with continuous efficacy
|
|
JP5986382B2
(ja)
|
2009-03-10 |
2016-09-06 |
ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ |
抗原提示細胞ターゲティング癌ワクチン
|
|
CN102781236B
(zh)
|
2009-12-31 |
2015-01-07 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
|
WO2011112657A1
(en)
|
2010-03-11 |
2011-09-15 |
Kempharm, Inc. |
Fatty acid conjugates of quetiapine, process for making and using the same
|
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
|
WO2011159537A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
US9156822B2
(en)
|
2010-07-02 |
2015-10-13 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine D2 receptors
|
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
|
ES2715562T3
(es)
|
2011-12-15 |
2019-06-04 |
Alkermes Pharma Ireland Ltd |
Profármacos de compuestos de amina secundaria
|
|
JP6262732B2
(ja)
|
2012-08-16 |
2018-01-17 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｎ型カルシウムチャネル遮断剤としての置換ピラゾール
|
|
CN104822660A
(zh)
|
2012-08-21 |
2015-08-05 |
詹森药业有限公司 |
阿立哌唑半抗原及其在免疫测定中的应用
|
|
EP2888285B1
(en)
|
2012-08-21 |
2024-04-17 |
Janssen Pharmaceutica NV |
Antibodies to aripiprazole haptens and use thereof
|
|
CA2882595C
(en)
|
2012-08-21 |
2019-06-04 |
Ortho-Clinical Diagnostics, Inc. |
Antibodies to olanzapine haptens and use thereof
|
|
CA2882560C
(en)
|
2012-08-21 |
2020-10-27 |
Ortho-Clinical Diagnostics, Inc. |
Haptens of risperidone and paliperidone for use in immunoassays
|
|
AU2013305938B2
(en)
|
2012-08-21 |
2017-08-17 |
Saladax Biomedical Inc. |
Antibodies to paliperidone haptens and use thereof
|
|
ES2666000T3
(es)
|
2012-08-21 |
2018-04-30 |
Janssen Pharmaceutica, N.V. |
Anticuerpos para aripiprazol y uso de los mismos
|
|
US9394354B2
(en)
|
2012-08-21 |
2016-07-19 |
Janssen Pharmaceutica Nv |
Haptens of paliperidone
|
|
EP2888284B1
(en)
|
2012-08-21 |
2022-07-06 |
Janssen Pharmaceutica NV |
Antibodies to risperidone haptens and use thereof
|
|
US9410972B2
(en)
|
2012-08-21 |
2016-08-09 |
Janssen Pharmaceutica Nv |
Antibodies to quetiapine and use thereof
|
|
EP3492473A1
(en)
|
2012-08-21 |
2019-06-05 |
Janssen Pharmaceutica NV |
Haptens of olanzipine
|
|
CN104736561B
(zh)
|
2012-08-21 |
2018-06-12 |
詹森药业有限公司 |
帕潘立酮的抗体及其用途
|
|
US9304126B2
(en)
|
2012-08-21 |
2016-04-05 |
Janssen Pharmaceutica Nv |
Haptens of quetiapine
|
|
ES2691092T3
(es)
|
2012-08-21 |
2018-11-23 |
Janssen Pharmaceutica Nv |
Anticuerpos contra la risperidona y uso de los mismos
|
|
AU2013305901B2
(en)
|
2012-08-21 |
2017-10-26 |
Saladax Biomedical Inc. |
Antibodies to olanzapine and use thereof
|
|
CN110054693A
(zh)
*
|
2012-08-21 |
2019-07-26 |
詹森药业有限公司 |
喹硫平半抗原的抗体及其用途
|
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
|
WO2017106508A1
(en)
|
2015-12-17 |
2017-06-22 |
Janssen Pharmaceutica Nv |
Antibodies to quetiapine and use thereof
|
|
WO2017106501A1
(en)
|
2015-12-17 |
2017-06-22 |
Janssen Pharmaceutica Nv |
Antibodies to risperidone and use thereof
|
